Impaired endothelium-independent vascular smooth muscle reactivity negotiates the relationship between poor cognitive performance and high visceral adiposity in elderly adults with type 2 diabetes (T2D), according to a new Singapore study.
A large Canadian population-based study links living near major roads and highways with higher incidence of non-Alzheimer’s dementia (NAD), Parkinson’s disease (PD), Alzheimer’s disease (AD) and multiple sclerosis (MS).
A community-based prospective study of 921 older adults finds evidence that a diet high in flavonols, particularly kaempferol and isorhamnetin, may be protective against the development of Alzheimer’s dementia.
The dual orexin receptor antagonist lemborexant effectively promotes sleep by improving both the onset and maintenance of sleep compared with placebo or zolpidem in older patients with insomnia, the SUNRISE 1* trial has shown.
The GLP-1 receptor agonist* dulaglutide may reduce the incidence of stroke, particularly ischaemic stroke, in individuals with type 2 diabetes (T2D) and cardiovascular (CV) risk factors, according to findings of an exploratory analysis of the REWIND** trial.
In the treatment of idiopathic generalized epilepsy, switching from valproate to other antiepileptic drugs due to potential childbearing issues may prove detrimental, heightening the risk of poor seizure control, as shown in a recent study.
Treatment with intravenous immunoglobulin (IVIG) offers significant pain relief in patients with painful diabetic polyneuropathy (DPN) resistant to standard therapies, without deleterious side effects, according to the results of a trial.
A Spanish prospective multicentre study has identified a wider spectrum of paediatric demyelinating and encephalitic syndromes associated with myelin oligodendrocyte glycoprotein (MOG) antibodies than previously reported.